Regulatory Compliance Audit Case Study

This case study details the engagement of ProPharma Group, LLC to address inadequacies in a client's initial qualification audit for contract manufacturing organizations (CMOs). The initial audit, performed by a consulting firm, focused narrowly on facilities and equipment systems, neglecting other critical areas such as quality, production, and laboratory controls. This oversight left the client vulnerable to regulatory risks. ProPharma was subsequently engaged to conduct a more comprehensive surveillance audit, which uncovered significant discrepancies, including three critical and seven major observations. The audit findings prompted the development of a remediation plan in collaboration with the CMO. The successful implementation of this plan ensured that all major observations were addressed before the Phase III manufacture of the drug product. As a result, the sponsor achieved a lower compliance risk and gained confidence in the safety and effectiveness of the materials produced for clinical trials. The case study illustrates the importance of thorough auditing in maintaining regulatory compliance.